Cell Therapy Biomanufacturing: Global Markets

Report Scope:

This research report presents an in-depth analysis of the global cell therapy biomanufacturing market by product type, application and region. The report discusses the key inhibitors to the growth of cell therapy biomanufacturing. The report discusses the role of participants in the supply chain from manufacturers to researchers. The report analyzes key companies operating in the global cell therapy biomanufacturing market. In-depth patent analysis in the report will provide a look at the existing and coming technological trends.

In this report, the cell therapy biomanufacturing market is segmented by product type, application and region. Based on product type, the market is segmented into source of cells (T-cells, Dendritic cells, tumor cells and stem cells), and type of therapy (autologous cell therapies, allogeneic cell therapies). The market by application is categorized into cardiovascular diseases, bone repair, neurological disorders, skeletal muscle repair, cancer and others. The market by region is segmented into North America, Europe, Asia-Pacific and ROW.

Report Includes:

- 23 tables
- An overview of the global markets for cell therapy biomanufacturing
- Estimation of the market size and analyses of global market trends with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Assessment of market dynamics such as drivers, restraints, opportunities, and identification of growth inhibiting areas that affect the global market
- Detailed description of allogeneic (third party donor cells) and autologous (ones own body cells) forms of cell therapy and analysis of its advantages and limitations
- Information on clinical trials of cell therapies; insights into regulatory scenarios and initiatives by government organization
- Evaluation of current market trends, market size, market forecast, and technological advancements within the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies; and a relevant patent analysis
- Company profiles of major players of the industry, including Bristol-Myers Squibb Co., Caladrius Biosciences Inc., Lonza Group Ltd., Merck KGaA and Novartis AG"

Summary:

There are numerous indications that can be cured using cell therapies, and the number of therapeutic uses is expected to increase. Some of the indications under investigation for treatments using cell therapy are cerebral disorders such as Parkinson’s disease and Alzheimer’s disease, and cardiovascular disease. Cardiovascular disease could be treated using cell therapies with the aim of restoring normal heart function. Moreover, many studies are underway to improve the safety and efficacy in the treatment of different malignancies. Cell therapy could also be used to cure metabolic disorders such as diabetes mellitus type 1, where there is lack of insulin production in the patient. Researchers are also trying to restore normal liver and kidney function by introducing modified cells of respective origins. Cell therapy is also a promising technique for the treatment of orthopedic, oncological, neurological and autoimmune diseases. The increase in the potential of cell therapies in the treatment of diseases associated with lungs using stem cell therapies is expected to be a major driver of the market’s growth. Another driver is improved understanding of the role of stem cells in inducing development of functional lung cells, from both embryonic stem cells (ESCs) and induced pluripotent stem (iPS) cells. Stem cell therapies provides further understanding of lung biology and repair after lung injury.

An increase in the incidence of cardiovascular diseases, rise in the demand for chimeric antigen receptor (CAR) T cell therapy, and further development of stem cell therapy approaches are driving the market’s growth. However, market restraints include the bottlenecks experienced by manufacturers during commercialization of cell therapies and the high costs associated with cell therapies. The rise in the development of allogeneic cell therapy is expected to drive the market’s growth. Allogeneic cell therapy involves chemo radiotherapeutic conditioning therapy that is followed by transplantation of hematopoietic stem cells as well as lymphocytes isolated from allogeneic healthy donors for treatment of various chronic diseases. (Allogeneic means from “one person to another,” vs. autologous, which means from “one person back to the same person after processing.”)

Hematopoietic stem cell transplantation is used for treatment of a variety of blood cancers and hematologic conditions. This transplantation is the most frequently used cell therapy procedure.

In this report, the cell therapy biomanufacturing market is segmented by product type, application and region. The market by application is classified into cardiovascular diseases, bone repair, neurological disorders, skeletal muscle repair and others. The market by product time generated the highest revenue in 2019, and is anticipated to reach REDACTED by 2025, registering a compound annual growth rate (CAGR) of REDACTED. Skeletal/muscle repair generated the highest revenue among applications in 2019, and is anticipated to reach REDACTED by 2025, registering a CAGR of REDACTED. However, neurological diseases related to cell therapy biomanufacturing will grow at a faster rate, registering a CAGR of REDACTED from 2020 to 2025. North America has the largest global cell therapy biomanufacturing market, whereas Asia-Pacific is the fastest-growing region.

 Chapter 1 Introduction
 Study Goals and Objectives
 Reasons for Doing This Study
 Scope of Report
 Methodology
 Market Estimates
 Information Sources
 Primary Research
 Secondary Research
 Geographic Breakdown
 Analyst’s Credentials
 BCC Custom Research
 Related BCC Research Reports

 Chapter 2 Summary and Highlights
 Introduction

 Chapter 3 Market and Technology Background
 Introduction to Cell Therapy Biomanufacturing
 What is Cell Therapy?
 Stem Cell Transplantation
 Autologous
 Allogeneic
 Syngeneic
 Stem Cell Biomanufacturing and Classification
 Based on Ability to Differentiate
 Based on Source
 Classification of Cell-Based Therapy Technology
 Somatic Cell Technologies
 Three-Dimensional Technologies
 Cell Immortalization Technologies
 Genome Editing Technologies
 Cell Plasticity Technologies
 Ex vivo Gene Modification of Cells Using Viral Vector Technologies
 In vivo Gene Modification of Cells Using Viral Vector Technologies
 Stem Cell Applications
 Mechanism of Cell Therapy
 Delivery Method of Cell-Based Therapy
 Manufacturing Cell Therapy Models
 Role of Contract Manufacturers
 Ongoing Clinical Trials
 Clinical Trial Network Focused on Stem Cell Treatments

 Chapter 4 Market Trends and Challenges
 Challenges
 Drivers
 Restraints
 Opportunity

 Chapter 5 Market Breakdown by Product Type
 Type of Therapy
 Source of Cells
 Rise in the Demand for Chimeric Antigen Receptor (CAR) T Cell Therapy

 Chapter 6 Market Breakdown by Application
 Cardiovascular Disease
 Microparticles Cell Imitation
 Bone Repair
 Neurological Disorders
 Spinal Cord Injury
 Stroke
 Parkinson’s Disease
 Amyotrophic Lateral Sclerosis
 Multiple Sclerosis
 Cerebral Palsy
 Alzheimers Disease
 Vision Restoration
 Vertebral Repair
 Battens Disease
 Skeletal Muscle Repair
 Intrinsic Healing Mechanisms
 Cell Therapy Mechanism
 Cancer
 Other Diseases

 Chapter 7 Market Breakdown by Region
 Market Overview
 North America
 U.S.
 Canada
 Mexico
 Europe
 Cardiovascular Diseases in Europe
 Contributing Factors for Cardiovascular Diseases (CVD)
 Germany
 U.K.
 France
 Asia-Pacific
 China
 India
 Japan
 Rest of APAC
 Rest of the World
 South America
 Middle East and Africa

 Chapter 8 Regulatory Structure
 FDA Approvals
 Cell Therapy for CBER Regulations
 Federal Regulation codes
 Collection of Cells
 Code of Regulation
 Legislation Governing Use of Stem Cell Treatments
 EU Determination of Regulatory Status
 Regulatory Scenario in India

 Chapter 9 Company Profiles
 BONE THERAPEUTICS SA
 BRISTOL-MYERS SQUIBB CO.
 CALADRIUS BIOSCIENCES INC.
 CELL THERAPIES PTY LTD.
 CELLULAR BIOMEDICINE GROUP INC.
 IOVANCE BIOTHERAPEUTICS INC.
 LONZA GROUP LTD.
 MERCK KGAA
 NEUROGENERATION INC.
 NOVARTIS AG
 REGEN BIOPHARMA INC.
 REGENEUS LTD.

 Chapter 10 Appendix: References
 Sources


List Of Tables

 Summary Table : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2025
 Table 1 : Types of Stem Cells
 Table 2 : Global Market for Cell Therapy Biomanufacturing, by Type of Therapy, Through 2025
 Table 3 : Global Market for Cell Therapy Biomanufacturing, by Source of Cells, Through 2025
 Table 4 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2025
 Table 5 : Treatments for Cardiovascular Diseases
 Table 6 : Global Market for Cell Therapy Biomanufacturing for Cardiovascular Disease Applications, Through 2025
 Table 7 : Global Market for Cell Therapy Biomanufacturing for Bone Repair Applications, Through 2025
 Table 8 : Global Market for Cell Therapy Biomanufacturing for Neurological Disorder Applications, Through 2025
 Table 9 : Global Market for Cell Therapy Biomanufacturing for Skeletal Muscle Repair Applications, Through 2025
 Table 10 : Global Market for Cell Therapy Biomanufacturing for Cancer Treatment Applications, Through 2025
 Table 11 : Global Market for Cell Therapy Biomanufacturing for Other Applications, Through 2025
 Table 12 : North American Market for Cell Therapy Biomanufacturing, by Country, Through 2025
 Table 13 : European Market for Cell Therapy Biomanufacturing, by Country, Through 2025
 Table 14 : Asia-Pacific Market for Cell Therapy Biomanufacturing, by Country, Through 2025
 Table 15 : Stem Cell Treatment Provided in Australia
 Table 16 : Bone Therapeutics: Products
 Table 17 : Bristol-Myers Squibb: Net Revenue, 2017-2019
 Table 18 : Caladrius Biosciences: Products
 Table 19 : Iovance Biotherapeutics: Products
 Table 20 : Merck KGaA: Products
 Table 21 : Regen BioPharma: Products
 Table 22 : Regeneus: Products


List Of Figures

 Summary Figure : Global Market for Cell Therapy Biomanufacturing, by Product Type, 2019-2025
 Figure 1 : Combination of Stem Cells and Biomaterials
 Figure 2 : Global Market for Cell Therapy Biomanufacturing Market, by Product Type, 2019-2025
 Figure 3 : Autologous and Allogeneic Cell Therapy Based on Source
 Figure 4 : Mechanism of Bone Marrow
 Figure 5 : Global Market for Cell Therapy Biomanufacturing, by Region, 2019-2025
 Figure 6 : Global Market Share for Cell Therapy Biomanufacturing, by Region, 2025
 Figure 7 : North American Market for Cell Therapy Biomanufacturing, 2019-2025
 Figure 8 : North American Market Share for Cell Therapy Biomanufacturing, by Country, 2019
 Figure 9 : European Market for Cell Therapy Biomanufacturing, 2019-2025
 Figure 10 : European Market Share for Cell Therapy Biomanufacturing, by Country, 2019
 Figure 11 : Asia-Pacific Market for Cell Therapy Biomanufacturing, 2019-2025
 Figure 12 : Asia-Pacific Market Share for Cell Therapy Biomanufacturing, by Country, 2019
 Figure 13 : South American Market for Cell Therapy Biomanufacturing, 2019-2025
 Figure 14 : Middle Eastern and African Market for Cell Therapy Biomanufacturing, 2019-2025
  


Global Placental Stem Cell Therapy Market Research Report 2021-2025

In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Placental Stem Cell Therapy Report by Material, Application, and Geography

USD 3200 View Report

Global CarT Cell Therapy Market Research Report 2021-2025

In this report, the global CarT Cell Therapy market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.

USD 2850 View Report

Global Placental Stem Cell Therapy Market Research Report 2021-2025

In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Placental Stem Cell Therapy Report by Material, Application, and Geography

USD 3200 View Report

Global CarT Cell Therapy Market Research Report 2021-2025

In this report, the global CarT Cell Therapy market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.

USD 2850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available